Skip to content
Contact Us
Contact Us
Adverse Event
UK and Ireland (UK & I)
Global
Argentina
Australia
Austria
Brazil
Canada
EN
FR
China
Denmark
Finland
France
Germany
Italy
Japan
Malaysia
MENA
Netherlands
Norway
Serbia
Singapore
South Africa
South Korea
Spain
Sweden
Switzerland
DE
FR
IT
United States
Medical Information
Tevimbra Patient Cards
Adverse Events
About
About Us
Our Offices
Science
Research and Development
Research & Development Overview
Disease Focus Areas: Haematology
Disease Focus Areas: Solid Tumours
Pioneering Protein Degradation with CDACs
Antibody Drug Conjugates
Pipeline
Find a Trial
Request Support
Patients
Our Commitment to Patients
Transparency
Global Patient Safety
Responsibility
Responsibility and Sustainability
CONNECT
Careers
Our Culture
See Open Positions
Contact Us
Contact Us
Adverse Event
UK and Ireland (UK & I)
Global
Argentina
Australia
Austria
Brazil
Canada
EN
FR
China
Denmark
Finland
France
Germany
Italy
Japan
Malaysia
MENA
Netherlands
Norway
Serbia
Singapore
South Africa
South Korea
Spain
Sweden
Switzerland
DE
FR
IT
United States
Medical Information
Tevimbra Patient Cards
Adverse Events
Menu
Tevimbra® (Tislelizumab): Patient Card
Download
